Hatcher James F, Swaminathan Santhanam
Department of Pharmacology and Environmental Health Science Center, University of Wisconsin, Madison, Wisconsin 53706, USA.
Environ Mol Mutagen. 2002;39(4):314-22. doi: 10.1002/em.10079.
DNA adducts formed in human uroepithelial cells (HUC) following exposure to N-hydroxy-4-aminobiphenyl (N-OH-ABP), the proximate metabolite of the human bladder carcinogen 4-aminobiphenyl (ABP), were analyzed by the (32)P-postlabeling method. Two adducts detected by (32)P-postlabeling were previously identified as the 3',5'-bisphospho derivatives of N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP) and N-(deoxyadenosin-8-yl)-4-aminobiphenyl (dA-C8-ABP) (Frederickson S et al. [1992] Carcinogenesis 13: 955-961; Hatcher and Swaminathan [1995b] Carcinogenesis 16: 295-301). In contrast to the dG-C8-ABP adduct, which was 3'-dephosphorylated by nuclease P1, dA-C8-ABP was resistant to nuclease P1, thus providing an enrichment step before postlabeling. Autoradiography of the two-dimensional thin-layer chromatogram of the postlabeled products obtained following nuclease P1 digestion revealed several minor adducts, one of which has been identified in the present study. Postlabeling analyses following nuclease P1 digestion of the products obtained from the reaction of N-acetoxy-4-aminobiphenyl with deoxyguanosine-3'-monophosphate (dGp) demonstrated the presence of this minor adduct. The 3'-monophosphate derivative of the adduct was subsequently chromatographically purified and subjected to spectroscopic analyses. Based on proton NMR and mass spectroscopic analyses of the synthetic product, the chemical structure of the adduct has been identified as N-(deoxyguanosin-N(2)-yl)-4-azobiphenyl (dG-N==N-ABP). (32)P-Postlabeling analysis of the nuclease P1-enriched DNA hydrolysate of HUCs treated with N-OH-ABP or N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP) showed the presence of the dG-N==N-ABP adduct. It was also detected in calf thymus DNA incubated with HUC cytosol and N-OH-ABP in the presence of acetyl-CoA, or incubated with HUC microsomes and N-OH-AABP. These results demonstrate that in the target cells for ABP carcinogenesis in vivo, N-OH-ABP and N-OH-AABP are bioactivated by acyltransferases to reactive arylnitrenium ions that covalently interact at the N2 position of deoxyguanosine in DNA.
采用³²P后标记法分析了人膀胱致癌物4-氨基联苯(ABP)的近端代谢产物N-羟基-4-氨基联苯(N-OH-ABP)暴露后人尿路上皮细胞(HUC)中形成的DNA加合物。³²P后标记法检测到的两种加合物先前已被鉴定为N-(脱氧鸟苷-8-基)-4-氨基联苯(dG-C8-ABP)和N-(脱氧腺苷-8-基)-4-氨基联苯(dA-C8-ABP)的3',5'-双磷酸衍生物(Frederickson S等人,[1992]《癌变》13: 955 - 961;Hatcher和Swaminathan,[1995b]《癌变》16: 295 - 301)。与被核酸酶P1 3'-去磷酸化的dG-C8-ABP加合物不同,dA-C8-ABP对核酸酶P1具有抗性,因此在进行后标记之前提供了一个富集步骤。核酸酶P1消化后获得的后标记产物的二维薄层色谱放射自显影片显示了几种次要加合物,其中一种在本研究中已被鉴定。对N-乙酰氧基-4-氨基联苯与脱氧鸟苷-3'-单磷酸(dGp)反应产物进行核酸酶P1消化后的后标记分析证明了这种次要加合物的存在。随后对该加合物的3'-单磷酸衍生物进行色谱纯化并进行光谱分析。基于合成产物的质子核磁共振和质谱分析,该加合物的化学结构已被鉴定为N-(脱氧鸟苷-N(2)-基)-4-偶氮联苯(dG-N==N-ABP)。对用N-OH-ABP或N-羟基-4-乙酰氨基联苯(N-OH-AABP)处理的HUCs经核酸酶P1富集的DNA水解产物进行³²P后标记分析,显示存在dG-N==N-ABP加合物。在小牛胸腺DNA与HUC细胞溶质和N-OH-ABP在乙酰辅酶A存在下孵育,或与HUC微粒体和N-OH-AABP孵育时也检测到了该加合物。这些结果表明,在体内ABP致癌作用的靶细胞中,N-OH-ABP和N-OH-AABP被酰基转移酶生物活化为活性芳基氮鎓离子,它们与DNA中脱氧鸟苷的N2位共价相互作用。